Table of Content

1. PREFACE
1.1. Chapter Overview
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3 INTRODUCTION
3.1. Chapter Overview
3.2. Viral Contamination in Biologics
3.3. Need for Viral Clearance and Testing
3.4. Process of Viral Clearance and Testing
3.5. Regulatory Guidelines Related to Viral Contamination
3.6. Future Perspectives

4. VIRAL CLEARANCE TESTING SERVICE PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Viral Clearance Testing Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters (Region)
4.2.5. Analysis by Location of Viral Clearance Testing Facilities
4.2.6. Analysis by Type of Virus Detected (by Envelope)
4.2.7. Analysis by Type of Virus Detected (by Class)
4.2.8. Analysis by Key Offerings
4.2.9 Analysis by Type of Biologic(s) Analyzed
4.2.10 Analysis by Method(s) of Viral Clearance (Inactivation)
4.2.11 Analysis by Method(s) of Viral Clearance (Removal)
4.2.12 Analysis by Type of Viral Testing Service(s) Offered

5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2 Methodology and Key Parameters
5.3. Viral Clearance Testing Service Providers in North America
5.4. Viral Clearance Testing Service Providers in Europe
5.5. Viral Clearance Testing Service Providers in Asia-Pacific and Rest of the World

6. VIRAL CLEARANCE TESTING SERVICE PROVIDERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. Charles River Laboratories
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Viral Clearance and Testing Related Services
6.2.4. Recent Developments and Future Outlook
6.3. Microbac Laboratories
6.3.1. Company Overview
6.3.2. Viral Clearance and Testing Related Services
6.3.3. Recent Developments and Future Outlook
6.4. Nelson Labs (subsidiary of Sotera Health)
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Viral Clearance and Testing Related Services
6.4.4. Recent Developments and Future Outlook
6.5. Pall (subsidiary of Danaher)
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Viral Clearance and Testing Related Services
6.5.4. Recent Developments and Future Outlook

7. VIRAL CLEARANCE TESTING SERVICE PROVIDERS IN EUROPE AND ASIA-PACIFIC
7.1. Chapter Overview
7.2. Eurofins Scientific
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. Viral Clearance and Testing Related Services
7.2.4. Recent Developments and Future Outlook
7.3. Syngene International
7.3.1. Company Overview
7.3.2. Financial Information
7.3.3. Viral Clearance and Testing Related Services
7.3.4. Recent Developments and Future Outlook
7.4. Texcell
7.4.1. Company Overview
7.4.2. Viral Clearance and Testing Related Services
7.4.3. Recent Developments and Future Outlook

8. PATENT ANALYSIS
8.1. Chapter Overview
8.2. Scope and Methodology
8.3. Viral Clearance Testing: Patent Analysis
8.3.1. Analysis by Patent Publication Year
8.3.2. Analysis by Patent Applications
8.3.3. Analysis by Type of Patent and Patent Publication Year
8.3.4. Analysis by Type of Organization
8.3.5. Word Cloud Analysis: Emerging Focus Areas
8.3.6. Analysis by Geography
8.3.7. Analysis by CPC Symbols
8.3.8. Leading Players: Analysis by Number of Patents
8.4. Viral Clearance Testing : Patent Benchmarking Analysis
8.4.1. Analysis by Patent Characteristics
8.5. Viral Clearance and Testing Services: Patent Valuation Analysis
8.6. Leading Patents by Number of Citations

9. RECENT DEVELOPMENTS
9.1 Chapter Overview
9.2. Partnerships and Collaborations
9.2.1. Partnership Models
9.2.2. Viral Clearance Testing Service Providers: List of Partnerships and Collaborations
9.2.3. Analysis by Year of Partnership
9.2.4. Analysis by Type of Partnership
9.2.5. Analysis by Year and Type of Partnership
9.2.6. Analysis by Purpose of Partnership
9.2.7. Analysis by Type of Organization
9.2.8. Analysis by Location of Facility (Country)
9.2.9. Analysis by Location of Facility (Region)
9.2.10. Most Active Players: Analysis by Number of Partnerships
9.2.11. Analysis by Geography
9.2.11.1. Intercontinental and Intracontinental Agreements
9.3. Recent Expansions
9.3.1. Viral Clearance Testing Service Providers: List of Recent Expansions
9.3.2. Analysis by Year of Expansion
9.3.3. Analysis by Type of Expansion
9.3.4. Analysis by Focus of Expansion
9.3.5. Analysis by Type of Service(s) Offered
9.3.6. Analysis by Type of Biologic(s) Involved
9.3.7. Analysis by Type of Expansion and Biologic(s) Involved
9.3.8. Most Active Players: Analysis by Number of Expansions
9.3.9. Analysis by Geography

10. VIRAL CLEARANCE TESTING SERVICES: MARKET FORECAST AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Global Viral Clearance Market, 2023-2035
10.3.1. Global Viral Clearance Market: Distribution by Scale of Operation, 2023 and 2035
10.3.1.1. Viral Clearance Market for Discovery Phase, 2023-2035
10.3.1.2. Viral Clearance Market for Preclinical Phase, 2023-2035
10.3.1.3. Viral Clearance Market for Clinical Phase, 2023-2035
10.3.2. Global Viral Clearance Market: Distribution by Method of Viral Clearance and Testing, 2023 and 2035
10.3.2.1. Viral Clearance Market for Viral Detection, 2023-2035
10.3.2.2. Viral Clearance Market for Viral Inactivation, 2023-2035
10.3.2.3. Viral Clearance Market for Viral Removal, 2023-2035
10.3.3. Global Viral Clearance Market: Distribution by End-User, 2023 and 2035
10.3.3.1. Viral Clearance Market for Biotechnology and Pharmaceutical Companies, 2023-2035
10.3.3.2. Viral Clearance Market for Academic / Research Institutes, 2023-2035
10.3.4. Global Viral Clearance Market: Distribution by Key Geographical Regions, 2023 and 2035
10.3.4.1. Viral Clearance Market in North America, 2023-2035
10.3.4.2. Viral Clearance Market in Europe, 2023-2035
10.3.4.3. Viral Clearance Market in Asia-Pacific, 2023-2035
10.3.4.4. Viral Clearance Market in Rest of the World, 2023-2035

11. CONCLUSION

12. EXECUTIVE INSIGHTS

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS